Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-21

Clinical Trial Update: Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating lidocaine as an adjuvant to ketamine for induction of anesthesia in septic shock patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: Cairo University | Conditions: Septic Shock, Anesthesia | Phase 3 | Status: UNKNOWN